$ITCI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Intra-Cellular Therapies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Intra-Cellular Therapies, Inc.. Get notifications about new insider transactions in Intra-Cellular Therapies, Inc. for free.
Page: < prev 1 2 3 4 5 6 6 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 12.73 | 172,697 | 2,198,433 | 172,697 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 11.82 | 7,539 | 89,111 | 1,145,311 | 1.2 M to 1.1 M (-0.65 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 6,604 | 0 | 0 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 11.38 | 38,059 | 433,111 | 1,152,850 | 1.2 M to 1.2 M (-3.20 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 12.43 | 6,604 | 82,088 | 1,138,707 | 1.1 M to 1.1 M (-0.58 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 6,604 | 0 | 1,190,909 | 1.2 M to 1.2 M (+0.56 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 11.82 | 7,539 | 89,111 | 1,145,311 | 1.2 M to 1.1 M (-0.65 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | A | 0.00 | 58,915 | 0 | 58,915 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 11.38 | 38,059 | 433,111 | 1,152,850 | 1.2 M to 1.2 M (-3.20 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | A | 12.73 | 80,951 | 1,030,506 | 80,951 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 6,604 | 0 | 1,190,909 | 1.2 M to 1.2 M (+0.56 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 3,108 | 0 | 0 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | A | 0.00 | 58,915 | 0 | 58,915 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | A | 12.73 | 80,951 | 1,030,506 | 80,951 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 12.42 | 3,108 | 38,601 | 191 | 3.3 K to 191 (-94.21 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 3,108 | 0 | 0 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 11.80 | 5,398 | 63,696 | 3,299 | 8.7 K to 3.3 K (-62.07 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 12.42 | 3,108 | 38,601 | 191 | 3.3 K to 191 (-94.21 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 11.80 | 5,398 | 63,696 | 3,299 | 8.7 K to 3.3 K (-62.07 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 11.34 | 16,060 | 182,120 | 8,697 | 24.8 K to 8.7 K (-64.87 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 11.34 | 16,060 | 182,120 | 8,697 | 24.8 K to 8.7 K (-64.87 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 3,108 | 0 | 24,757 | 21.6 K to 24.8 K (+14.36 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 3,108 | 0 | 24,757 | 21.6 K to 24.8 K (+14.36 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | A | 0.00 | 58,915 | 0 | 58,915 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | A | 0.00 | 58,915 | 0 | 58,915 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | A | 12.73 | 80,951 | 1,030,506 | 80,951 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | A | 12.73 | 80,951 | 1,030,506 | 80,951 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 3,108 | 0 | 0 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 3,108 | 0 | 0 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Gift | G | 0.00 | 1,200 | 0 | 15,832 | 17 K to 15.8 K (-7.05 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Gift | G | 0.00 | 1,200 | 0 | 15,832 | 17 K to 15.8 K (-7.05 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 12.42 | 3,108 | 38,601 | 17,032 | 20.1 K to 17 K (-15.43 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 12.42 | 3,108 | 38,601 | 17,032 | 20.1 K to 17 K (-15.43 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 11.84 | 1,742 | 20,625 | 20,140 | 21.9 K to 20.1 K (-7.96 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 11.84 | 1,742 | 20,625 | 20,140 | 21.9 K to 20.1 K (-7.96 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 11.42 | 19,716 | 225,157 | 21,882 | 41.6 K to 21.9 K (-47.40 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 11.42 | 19,716 | 225,157 | 21,882 | 41.6 K to 21.9 K (-47.40 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 3,108 | 0 | 41,598 | 38.5 K to 41.6 K (+8.07 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 3,108 | 0 | 41,598 | 38.5 K to 41.6 K (+8.07 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | A | 0.00 | 58,915 | 0 | 58,915 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | A | 12.73 | 80,951 | 1,030,506 | 80,951 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | A | 0.00 | 58,915 | 0 | 58,915 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | A | 12.73 | 80,951 | 1,030,506 | 80,951 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | M | 0.00 | 1,554 | 0 | 0 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | M | 0.00 | 1,554 | 0 | 0 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Sell | S | 12.29 | 592 | 7,276 | 27,068 | 27.7 K to 27.1 K (-2.14 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Sell | S | 12.29 | 592 | 7,276 | 27,068 | 27.7 K to 27.1 K (-2.14 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Sell | S | 11.81 | 2,184 | 25,793 | 27,660 | 29.8 K to 27.7 K (-7.32 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Sell | S | 11.81 | 2,184 | 25,793 | 27,660 | 29.8 K to 27.7 K (-7.32 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Sell | S | 11.37 | 7,380 | 83,911 | 29,844 | 37.2 K to 29.8 K (-19.83 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Sell | S | 11.37 | 7,380 | 83,911 | 29,844 | 37.2 K to 29.8 K (-19.83 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Buy | M | 0.00 | 1,554 | 0 | 37,224 | 35.7 K to 37.2 K (+4.36 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Buy | M | 0.00 | 1,554 | 0 | 37,224 | 35.7 K to 37.2 K (+4.36 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | A | 0.00 | 54,988 | 0 | 54,988 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | A | 0.00 | 54,988 | 0 | 54,988 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | A | 12.73 | 75,554 | 961,802 | 75,554 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | A | 12.73 | 75,554 | 961,802 | 75,554 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Sell | S | 11.80 | 2,702 | 31,884 | 43,989 | 46.7 K to 44 K (-5.79 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Sell | S | 11.80 | 2,702 | 31,884 | 43,989 | 46.7 K to 44 K (-5.79 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Sell | S | 11.33 | 6,862 | 77,746 | 46,691 | 53.6 K to 46.7 K (-12.81 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Sell | S | 11.33 | 6,862 | 77,746 | 46,691 | 53.6 K to 46.7 K (-12.81 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 34,340 | 0 | 68,681 | |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 11,258 | 0 | 11,258 | |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 34,340 | 0 | 1,184,305 | 1.1 M to 1.2 M (+2.99 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 11,258 | 0 | 1,149,965 | 1.1 M to 1.1 M (+0.99 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 11.09 | 17,478 | 193,831 | 1,138,707 | 1.2 M to 1.1 M (-1.51 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Grant | A | 0.00 | 17,478 | 0 | 1,156,185 | 1.1 M to 1.2 M (+1.53 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 16,160 | 0 | 32,320 | |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 5,298 | 0 | 5,298 | |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 16,160 | 0 | 21,649 | 5.5 K to 21.6 K (+294.41 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 5,298 | 0 | 5,489 | 191 to 5.5 K (+2,773.82 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 11.09 | 7,807 | 86,580 | 191 | 8 K to 191 (-97.61 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Grant | A | 0.00 | 7,807 | 0 | 7,998 | 191 to 8 K (+4,087.43 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | M | 0.00 | 16,160 | 0 | 32,320 | |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | M | 0.00 | 2,649 | 0 | 2,649 | |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Buy | M | 0.00 | 16,160 | 0 | 35,670 | 19.5 K to 35.7 K (+82.83 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Buy | M | 0.00 | 2,649 | 0 | 19,510 | 16.9 K to 19.5 K (+15.71 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Sell | S | 11.10 | 4,834 | 53,657 | 16,861 | 21.7 K to 16.9 K (-22.28 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Grant | A | 0.00 | 9,322 | 0 | 21,695 | 12.4 K to 21.7 K (+75.34 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | M | 0.00 | 16,160 | 0 | 32,320 | |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | M | 0.00 | 2,649 | 0 | 2,649 | |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Buy | M | 0.00 | 16,160 | 0 | 53,553 | 37.4 K to 53.6 K (+43.22 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Buy | M | 0.00 | 2,649 | 0 | 37,393 | 34.7 K to 37.4 K (+7.62 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Sell | S | 11.11 | 4,834 | 53,706 | 34,744 | 39.6 K to 34.7 K (-12.21 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Grant | A | 0.00 | 9,322 | 0 | 39,578 | 30.3 K to 39.6 K (+30.81 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 16,160 | 0 | 32,320 | |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 5,298 | 0 | 5,298 | |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 16,160 | 0 | 38,490 | 22.3 K to 38.5 K (+72.37 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 5,298 | 0 | 22,330 | 17 K to 22.3 K (+31.11 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 11.09 | 7,807 | 86,580 | 17,032 | 24.8 K to 17 K (-31.43 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Grant | A | 0.00 | 7,807 | 0 | 24,839 | 17 K to 24.8 K (+45.84 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 11.39 | 512 | 5,832 | 4,955 | 4.4 K to 5 K (+11.52 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 11.39 | 1,273 | 14,499 | 40,057 | 38.8 K to 40.1 K (+3.28 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 11.39 | 1,207 | 13,748 | 11,430 | 10.2 K to 11.4 K (+11.81 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 11.39 | 1,273 | 14,499 | 748,916 | 747.6 K to 748.9 K (+0.17 %) |
| Dec 11 2018 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 1.50 | 50,000 | 75,000 | 0 | |
| Dec 11 2018 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 1.50 | 50,000 | 75,000 | 1,138,707 | 1.1 M to 1.1 M (+4.59 %) |
| Dec 07 2018 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | M | 0.00 | 1,758 | 0 | 0 | |
| Dec 07 2018 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Sell | S | 13.53 | 899 | 12,163 | 30,256 | 31.2 K to 30.3 K (-2.89 %) |
| Dec 07 2018 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Buy | M | 0.00 | 1,758 | 0 | 31,155 | 29.4 K to 31.2 K (+5.98 %) |
| Nov 13 2018 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Sell | S | 17.94 | 7,000 | 125,580 | 78,742 | 85.7 K to 78.7 K (-8.16 %) |
| Nov 13 2018 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Sell | S | 18.24 | 25,000 | 456,000 | 85,742 | 110.7 K to 85.7 K (-22.57 %) |
| Oct 24 2018 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | M | 1.50 | 12,500 | 18,750 | 0 | |
| Oct 24 2018 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Buy | M | 1.50 | 12,500 | 18,750 | 66,911 | 54.4 K to 66.9 K (+22.97 %) |
| Oct 17 2018 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 40,344 | 0 | 40,344 | |
| Oct 17 2018 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | A | 18.59 | 55,300 | 1,028,027 | 55,300 | |
| Oct 02 2018 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 21.70 | 633 | 13,736 | 54,411 | 53.8 K to 54.4 K (+1.18 %) |
| Oct 02 2018 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 21.70 | 668 | 14,496 | 38,784 | 38.1 K to 38.8 K (+1.75 %) |
| Oct 02 2018 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 21.70 | 268 | 5,816 | 4,443 | 4.2 K to 4.4 K (+6.42 %) |
| Oct 02 2018 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 21.70 | 668 | 14,496 | 747,643 | 747 K to 747.6 K (+0.09 %) |
| Jul 03 2018 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 17.67 | 820 | 14,489 | 38,116 | 37.3 K to 38.1 K (+2.20 %) |
| Jun 20 2018 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Option Exercise | A | 0.00 | 14,189 | 0 | 14,189 | |
| Jun 20 2018 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | A | 0.00 | 14,189 | 0 | 14,189 | |
| Jun 20 2018 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 20.39 | 20,000 | 407,800 | 20,000 | |
| Jun 20 2018 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | A | 20.39 | 20,000 | 407,800 | 20,000 | |
| Jun 20 2018 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | A | 0.00 | 14,189 | 0 | 14,189 | |
| Jun 20 2018 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 20.39 | 20,000 | 407,800 | 20,000 | |
| Jun 20 2018 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | A | 20.39 | 20,000 | 407,800 | 20,000 | |
| Jun 20 2018 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Option Exercise | A | 20.39 | 20,000 | 407,800 | 20,000 | |
| Jun 20 2018 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Option Exercise | A | 20.39 | 20,000 | 407,800 | 20,000 | |
| Apr 03 2018 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 21.05 | 653 | 13,746 | 10,223 | 9.6 K to 10.2 K (+6.82 %) |
| Apr 03 2018 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 21.05 | 653 | 13,746 | 10,223 | 9.6 K to 10.2 K (+6.82 %) |
| Apr 03 2018 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 21.05 | 688 | 14,482 | 37,296 | 36.6 K to 37.3 K (+1.88 %) |
| Feb 20 2018 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Sell | S | 20.01 | 16,319 | 326,543 | 17,032 | 33.4 K to 17 K (-48.93 %) |
| Feb 20 2018 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Sell | S | 20.03 | 33,381 | 668,621 | 33,351 | 66.7 K to 33.4 K (-50.02 %) |
| Jan 24 2018 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Sell | S | 18.03 | 25,500 | 459,765 | 191 | 25.7 K to 191 (-99.26 %) |
| Jan 10 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Sell | S | 17.46 | 772 | 13,479 | 12,373 | 13.1 K to 12.4 K (-5.87 %) |
| Jan 10 2018 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 17.48 | 6,604 | 115,438 | 1,088,707 | 1.1 M to 1.1 M (-0.60 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 0.00 | 103,021 | 0 | 103,021 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 15.47 | 138,473 | 2,142,177 | 138,473 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 6,604 | 0 | 6,604 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 11,257 | 0 | 22,516 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 17.08 | 11,257 | 192,270 | 1,095,311 | 1.1 M to 1.1 M (-1.02 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 6,604 | 0 | 1,106,568 | 1.1 M to 1.1 M (+0.60 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 11,257 | 0 | 1,099,964 | 1.1 M to 1.1 M (+1.03 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | A | 0.00 | 48,480 | 0 | 48,480 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | A | 15.47 | 65,164 | 1,008,087 | 65,164 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | M | 0.00 | 1,554 | 0 | 1,554 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | M | 0.00 | 2,648 | 0 | 5,298 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Sell | S | 17.37 | 1,185 | 20,583 | 13,145 | 14.3 K to 13.1 K (-8.27 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Buy | M | 0.00 | 1,554 | 0 | 14,330 | 12.8 K to 14.3 K (+12.16 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Buy | M | 0.00 | 2,648 | 0 | 12,776 | 10.1 K to 12.8 K (+26.15 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | A | 0.00 | 48,480 | 0 | 48,480 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | A | 15.47 | 65,164 | 1,008,087 | 65,164 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | M | 0.00 | 2,648 | 0 | 5,298 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Sell | S | 15.60 | 1,115 | 17,394 | 29,397 | 30.5 K to 29.4 K (-3.65 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Buy | M | 0.00 | 2,648 | 0 | 30,512 | 27.9 K to 30.5 K (+9.50 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | A | 0.00 | 48,480 | 0 | 48,480 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | A | 15.47 | 65,164 | 1,008,087 | 65,164 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | M | 0.00 | 3,108 | 0 | 3,108 |